Latest News and Press Releases

Chemomab and Scipher announced a merger agreement to advance nebokitug into a Phase 2 precision medicine trial for the treatment of rheumatoid arthritis.

Ethos Laboratories announces the exclusive U.S. launch of CNSDose™ following a successful MolDX® Technical Assessment.

Dublin, July 07, 2026 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The Exosome...

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Gene Editing Therapeutics Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The Gene...

Dublin, July 03, 2026 (GLOBE NEWSWIRE) -- The "Crispr-Based Drug Development Platforms Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. ...

Dublin, July 01, 2026 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...

Dublin, June 25, 2026 (GLOBE NEWSWIRE) -- The "AI in Genomics Market Report 2026" has been added to ResearchAndMarkets.com's offering.The AI in genomics market is experiencing rapid growth, poised...

Dublin, June 25, 2026 (GLOBE NEWSWIRE) -- The "Proteins & Protein Crystals Market by Product Type, Structural, Specialty, Application, End User - Global Forecast to 2030" has been added to ...

CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion...

Steve Brown, founder and CEO of CureWise, will speak at Aspen Ideas: Health 2026, where he will launch the company’s AI-powered precision oncology platform